EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study

Zixiang Ye, Chenyue Liu, Enmin Xie, Hao-Yu Wang, Chenxi Song, Rui Zhang, Kefei Dou

Journal of Inflammation Research · 2026-09 · Volume 19 · 1-13

DOI: 10.2147/jir.s605148 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Zixiang Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academ…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The study aimed to assess the prognostic utility of composite Insulin resistance (IR)- various inflammation biomarkers for predicting poor outcomes in coronary artery disease (CAD) patients stratified by glycemic status.

Methods

The prospective cohort included 1947 CAD patients undergoing PCI with pre-procedural coronary computed tomography angiography. Novel composite biomarkers integrating insulin resistance and inflammation (TyG-hsCRP, CTI, and TyG-fat attenuation index [FAI]) were constructed and calculated. Patients were categorized by glycemic status (normoglycemia, prediabetes, diabetes). Three-year follow-up tracked MACE (all-cause death, non-fatal myocardial infarction, unplanned revascularization). Analyses involved Cox regression, Kaplan-Meier curves, restricted cubic splines, receiver operating characteristic curves, and subgroup analyses.

Results

MACE occurred in 171 patients (8.8%). After multivariable adjustment, high versus low biomarker levels were associated with increased MACE risk: hazard ratio (HR) 1.23 (95% CI, 1.03-1.74; P=0.025) for TyG-hsCRP, 1.39 (95% CI, 1.04-2.04; P=0.032) for CTI, and 2.32 (95% CI, 1.67-3.25; P 0.05).

Conclusion

Composite biomarkers integrating IR and inflammation provide modest incremental value in predicting MACE in CAD patients. The predictive utility of these biomarkers is modulated by underlying glycemic status, highlighting the role of local coronary inflammation and supporting their potential integration into risk stratification.

Schlagwörter

Stichwörter der Autor:innen

coronary artery diseasefat attenuation indexglycemic statusinsulin resistancelocal coronary inflammationmajor adverse cardiovascular eventssystemic inflammation

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Peopl…
  • Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • National Clinical Research Center for Cardiovascular Diseases, Beijing, People's Republic of China.
  • Department of Radiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Zitieren

APA

Ye, Z., Liu, C., Xie, E., Wang, H. Y., Song, C., Zhang, R., & Dou, K. (2026). Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study. Journal of Inflammation Research, Volume 19, 1-13. https://doi.org/10.2147/jir.s605148

Vancouver

Ye Z, Liu C, Xie E, Wang HY, Song C, Zhang R, et al. Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study. Journal of Inflammation Research. 2026;Volume 19:1-13. doi:10.2147/jir.s605148

BibTeX
@article{Ye2026,
  author = {Ye, Zixiang and Liu, Chenyue and Xie, Enmin and Wang, Hao-Yu and Song, Chenxi and Zhang, Rui and Dou, Kefei},
  title = {Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--13},
  doi = {10.2147/jir.s605148}
}
Kostenlos starten →